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Studies on molecular hydrogen have evolved tremendously from its humble beginnings and have continued to
change throughout the years. Hydrogen is extremely unique since it has the capability to act at the cellular level.
Hydrogen is qualified to cross the blood brain barrier, to enter the mitochondria, and even has the ability to
translocate to the nucleus under certain conditions. Once in these ideal locations of the cell, previous studies have
shown that hydrogen exerts antioxidant, anti-apoptotic, anti-inflammatory, and cytoprotective properties that are
beneficial to the cell. Hydrogen is most commonly applied as a gas, water, saline, and can be applied in a variety of
other mediums. There are also few side effects involving hydrogen, thus making hydrogen a perfect medical gas
candidate for the convention of novel therapeutic strategies against cardiovascular, cerebrovascular, cancer,
metabolic, and respiratory diseases and disorders. Although hydrogen appears to be faultless at times, there still are
several deficiencies or snares that need to be investigated by future studies. This review article seeks to delve and
comprehensively analyze the research and experiments that alludes to molecular hydrogen being a novel
therapeutic treatment that medicine desperately needs.
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History
Hydrogen has been shown to be an extremely useful
element that has been used in a vast range of disciplines.
Since its initial discovery, hydrogen has been effectively
applied in a variety of combinations with other elements
and different physical states. The role of hydrogen is
constantly evolving from its humble beginnings in the
chemistry field as a mysterious flammable gas, to its
aeronautic applications in balloons, and its emerging
role as a potential therapy in medicine (See Figure 1).
The first documented discovery of hydrogen was by
Philippus Aureolus Paracelsus in 1520. Paracelsus un-
knowingly discovered a flammable gas by burning some
metal with an acid and collecting the products (Royal
Chemistry Society). After Paracelsus discovered this* Correspondence: johnhzhang3910@yahoo.com
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reproduction in any medium, provided the ormysterious flammable gas, others replicated the process
and began working with the gas. However, hydrogen gas
never had an official or common name. It was not until
1783, that Lavoisier, who is often referred to as the
modern father of chemistry, used the French word
“hydrogene” to describe the gas (Royal Chemistry Society).
The first applications of hydrogen were of the aero-
nautical nature. In 1783, Frenchmen Jacques Charles
created the first hydrogen balloon carrier. Since then
and throughout time many other forms of hydrogen
filled balloons would follow along with some success
and disasters. One of the most infamous disasters in-
volving hydrogen gas is the explosion of Hindenburg, a
German passenger aircraft utilizing hydrogen gas [4].Characteristics
Hydrogen can be characterized as the lightest and most
abundant chemical element. A large amount of hydro-
gen is usually found in water and organic compounds,
which causes free hydrogen to be rare on Earth [5].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 The progress of hydrogen in history. A timeline of the history of molecular hydrogen [1-3].
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drogen is also an odorless, tasteless, colorless gas [6].
As a result of its unique features hydrogen has many
advantageous characteristics. One major advantage that
hydrogen contains is its ability to diffuse through mem-
branes and enter the cytosol. Hydrogen can also enter
the mitochondria and nucleus. This is extremely favor-
able since many known antioxidants lack the ability to
target organelles and are not as effective in this manner.
Molecular hydrogen is also believed to be advantageous
in medical procedures since it is able to maneuver
through the blood brain barrier. There also are few side
effects involving hydrogen. It is proposed that few side
effects occur, since it seems that hydrogen reacts with
strong oxidants and its levels does not seem to interfere
with cell signaling processes involving reactive oxygen
species [2].
Out of the numerous observations evolved the applica-
tions of hydrogen. In 1888, the Annals of Surgery had
recorded one of the very publications linking hydrogen
and medicine. At that point in time unnecessary lapa-
rotomies were often performed since it was very difficult
for surgeons to determine visceral injuries to the intes-
tines and the stomach. It was also reported that a sur-
geon was able to use hydrogen gas to insufflate the
gastro-intestinal canal to accurately determine and lo-
cate visceral injuries, avoiding unwarranted surgeries [3].
Modern uses
Today, hydrogen is still very instrumental and can be
found in an assortment of fashions concerning medicine
and scientific research. One medicinal approach thatemploys hydrogen is the breath hydrogen test. The breath
hydrogen test is performed by measuring the amount of
hydrogen that is produced by intestinal bacteria that are
constantly synthesizing hydrogen as a result of fermen-
tation of unabsorbed carbohydrates [7]. The analysis of
the results of the breath hydrogen test can serve as bio-
markers and can be also used to compute oral-cecal trans-
port, transit times, and overgrowth of bacteria. The breath
hydrogen test is also used as biomarkers in clinical and
scientific research ranging from biochemistry, dentistry,
and physiology [5].
In 2007, Ohsawa et al., published “Hydrogen acts as a
therapeutic antioxidant by selectively reducing cytotoxic
oxygen radicals” in Nature Medicine. Ohsawa et al., re-
ported that hydrogen is able to react with cytotoxic oxy-
gen radicals and protect against oxidative damage. These
conclusions were made based upon experiments obser-
ving a rat model of focal ischemia and reperfusion. After
ischemia was induced and reperfusion performed, it was
observed that arterial blood contained elevated levels
proportionate to the concentration of hydrogen that was
inhaled. Also, it is suggested that the tissue was able to
absorb hydrogen, since dissolved hydrogen was found at
lower levels than the arterial blood. The study also sug-
gests that hydrogen is able to prevent oxidative damage
by reacting with the hydroxyl radical. This is important
since the hydroxyl radical is believed to be the most
dangerous oxygen species since there are no naturally
occurring mechanisms to prevent its affects. As a result
of the findings by Ohsawa et al., the convention of
hydrogen has yet evolved. This publication has sparked
many investigations concerning hydrogen as a selective
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an antioxidant therapy [2].
Mechanisms
Anti-oxidation
The exact mechanisms of how hydrogen acts still remain
a mystery in the scientific community. One useful find-
ing by Kayar et al. showed that mammalian tissues under
hyperbaric conditions do not oxidize hydrogen, thus
leading to hydrogen being used as a non-metabolic por-
tion of breathing gas for deep divers [8]. However more
mysteries still remain. Mechanisms of hydrogen serving
as an antioxidant scavenger (specifically the hydroxyl
radical) have been established and confirmed by a num-
ber of scientists. However the exact mechanism of this
scavenging ability has not yet been discovered.
In 1975, Dole et al., was among one of the first to
propose that hydrogen had antioxidant abilities against
alkyl radicals and the hydroxyl radical. Dole et al., made
the initial observations and proposed that hydrogen
contained anti-cancer properties since hyperbaric hydro-
gen therapy degenerated squamous cell carcinomas. It
was reported that hydrogen therapy also had the capa-
bility of scavenging the hydroxyl radical by means of
an exothermic reaction. When an exothermic reaction
occurs hydrogen combines with the hydroxyl radical toFigure 2 Hydrogen therapy reduces hydroxyl radical and increases en
hydrogen is proposed to be protective by increasing endogenous antioxid
as oxidative stress [9,10].form water and hydrogen. The hydrogen generated from
the water forming reaction is then able to combine with
the superoxide radical, which causes another reaction
and prevents the formation of more peroxide and hy-
droxyl radicals.
More recent studies have also shown that hydrogen is
able to reduce ROS in vitro, as a result of its proposed
ability to scavenge the hydroxyl radical, “the most potent
oxidant known to mankind”[9,10]. When free radicals or
ROS accumulates, usually as a result of cellular pro-
cesses, it leads to oxidative stress. Oxidative stress can
cause serious damage to tissues and can lead to a variety
of diseases. It is also proposed that hydrogen is capable
of organ protection in cerebral ischemia, neonatal cere-
bral hypoxia ischemia, liver injuries, lung injuries, and
myocardial injuries all caused by ischemia reperfusion, a
condition that causes an increase in oxidative stress. In
addition it has been shown that hydrogen is able to
increase antioxidant enzymes to help suppress the disas-
trous effects of oxidative stress. A summary of the anti-
oxidant properties of hydrogen therapy is described in
Figure 2 [10].
Anti-inflammation
Hydrogen has also been described as containing anti-
inflammatory properties. Gharib et al. observed thesedogenous antioxidants caused by oxidative stress. Molecular
ants in addition to scavenging the hydroxyl radical after an injury such
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nic liver inflammation induced by the parasite Schistoso-
ma mansoni. It was suggested that hyperbaric hydrogen
treatment was able to improve liver hemodynamics and
reduce portal hypertension, as well as reduce liver fibro-
sis by attenuating inflammatory cytokines [11].
Cytoprotection
Although hydrogen has been strongly implicated with
reducing oxidative stress, it has been proposed that hy-
drogen effects signaling mechanisms and can also induce
cytoprotective factors [12,13].
In 2011, Itoh et al., demonstrated that hydrogen was
able to affect signal transduction and act as a signal mo-
dulator. Hydrogen was able to act in this manner by
inhibiting LPS/IFNγ-induced nitric oxide production in
macrophages, resulting in decreased inflammation in
Type I allergies. The exact molecules that hydrogen is
binding to and modulating are unknown, but it is pos-
sible to narrow down and determine specific sites. It was
confirmed that hydrogen was able to modulate signal
transduction, which suggests that hydrogen is a signal
modulator. Further studies need to be conducted to de-
termine exactly how, why, and under what conditions
that hydrogen can be a signal modulator [12]. Another
proposed mechanism for hydrogen is its ability to provide
cytoprotection by increasing other antioxidant enzymes
such as superoxide dismutase and catalase [10]. It is also

















Figure 3 Possible mechanisms of molecular hydrogen. Possible pathw
hydrogen has the capabilities to affect the pathways mentioned and to dir
the following: MPO, MCP, Caspase-3, Caspase-12, TNF, interleukins, Bcl-2, Bapreventing the activation of caspase-3, which through a
series of events can reduce apoptosis [13]. Shi et al. has
also proposed that molecular hydrogen may be able to af-
fect signal transduction by interacting with metallopro-
teins, since metal ions can be a possible binding site for
hydrogen [14].
Signal modulation
Recently, it has been reported that hydrogen may be able
to inhibit pathways as a result of its ability to reduce
levels of ROS. It has also been shown that molecular
hydrogen is able to inhibit the TNF-α/NFκβ pathway as
well as the Ras-ERK1/2-MEK1/2 and Akt pathways,
these findings as well as possible gene regulatory effects
are illustrated in Figure 3 [15,16]. The suppression of
these pathways by use of hydrogen was demonstrated in
neointimal hyperplasia models in rats. Further investiga-
tion of the suppression of these pathways should be
heavily investigated since these pathways are important;
and involved with inflammatory responses, gene regu-
lation, and apoptosis. The possibilities of the effects of
regulation of these two pathways and diseases alone are
quite high (See Figure 3) [16].
Administration of hydrogen
Three of the most common ways to administer hydrogen
as a treatment are: 1) inhaling hydrogen gas, 2) injecting
a hydrogen rich saline, 3) drinking hydrogen rich water.
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have shown that complications involving facemasks and
unattended patients, specifically neurologically impaired
patients, may cause inconsistencies with inhalation.
Generally hydrogen gas can be easily inhaled through
facemasks, ventilators, gas chambers, or nasal cannulas
[4,22]. It is also possible to administer hydrogen intra-
venously, by injecting hydrogen rich saline. Hydrogen
rich saline can be created by dissolving hydrogen in
physiological saline under high pressures. Hydrogen rich
saline is also able to provide more accurate concentra-
tions of hydrogen into the body [13]. Hydrogen rich
water can be easily generated by exposing water to mag-
nesium by dissolving electrolyzed hydrogen into water,
or by dissolving molecular hydrogen into water under
high pressures.
Once hydrogen has been generated in its chosen me-
dium, the levels of concentrations can easily be detected
as well. The concentration of hydrogen in aqueous and
gas solutions can be detected by using electrochemical
gas sensors. An alternative detection method that is less
expensive is using a methylene blue-platinum colloid
reagent [23].
There are also other forms of molecular hydrogen ad-
ministration, which include topical agents and room air
administration [24].
Potential of hydrogen in the top ten causes of death
At the time of the creation of this document, the most
recent data available to the public concerning the top
causes of death in the United States of America can be
found in a preliminary report by the Center for Disease
Control [25]. The CDC describes the following as
the top ten causes of death in America: cardiovascular
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Figure 4 Hydrogen therapy potential for top causes of death in the U
the United States (excluding deaths caused by suicide and accidents) [23].diseases, cerebrovascular diseases, accidents (unintentio-
nal injuries), Alzheimer’s disease, diabetes mellitus, influ-
enza and pneumonia, nephritis (nephritic syndrome and
nephrosis), and suicide (intentional harm). Interestingly
enough Figure 4 shows how hydrogen therapy can either
be linked or speculated to be a potential treatment in
each of those top causes of death excluding deaths be-
getting accidents (unintentional injuries) and suicides
(intentional harm) (See Figure 4).
Nephritis and nephritic syndrome
The effects of hydrogen rich water on gentamicin in-
duced nephrotoxicity was analyzed by Matsushita et al.
It was discovered that hydrogen rich water was able to
improve renal dysfunction caused by nephrotoxicity by
reducing oxidative stress as well as lowering serum crea-
tinine (Cr) and blood urea nitrogen (BUN) when com-
pared to control rats [26]. Positive results of hydrogen
rich saline were also observed when used as a treatment
after renal ischemia and reperfusion injury. Wang et al.
observed statistically significant decreases or reversals in
MDA levels, blood urea nitrogen levels, creatinine levels,
myeloperoxidase (MPO) levels, and pro-inflammatory
cytokines (TNF-α, IL-1β, and IL-6) when compared to
control counterparts. While increases in the antioxidants
superoxide dismutase and catalase as well as reversals in
apoptotic death were also observed. These results sug-
gest that hydrogen rich saline is effective in combating
renal ischemia and reperfusion injury [17].
One clinical trial that shows promise involves dis-
solved hydrogen being used as a treatment for haemo-
dialysis patients. To observe the effects of hydrogen
on the patients, a dialysis solution containing a high
concentration of dissolved hydrogen gas was created and
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months, the blood pressure, skin temperatures, markers
for oxidative stress, myeloperoxidase, myelocyte che-
moattractant protein (MCP), highly sensitive C-reactive
protein, and N terminal pro-brain natriuretic peptide for
the patients were all measured and monitored. The re-
sults showed that after treatment with hydrogen, high
blood pressure generally decreased for the patients and
some instances patients reached normotensive statuses.
There were also decreases in MCP and MPO, which are
chemokines and enzymes secreted by monocytes and
neutrophils respectively. The decrease in MCP and
MPO is believed to be representative of suppressed
inflammatory and white blood cell (specifically neu-
trophil) responses. The studies concluded that hydro-
gen was able to quell inflammation and improve blood
pressure [27].
The ROS scavenging abilities of hydrogen rich wa-
ter were demonstrated in experiments conducted by
Kitamura et al. Based on the results, the conclusion that
hydrogen rich water administration against cisplatin-
induced renal nephrotoxicity ameliorated the effects and
improved renal dysfunction was made. Altogether hy-
drogen rich mediums seem to improve the damaging or
even reverse in some instances the damaging effects
stemming from renal dysfunction and nephrotoxicity;
and may have a potential in combating nephritis and
nephritic syndrome [28].
Diabetes mellitus
Skin lesions are a common condition that can develop
as a result of diabetes mellitus. Recently, it has been
shown that the production of oxidative stress by high
levels of blood glucose causes an overproduction of
ROS, which may result in a possible pathogenesis to dia-
betic skin lesions. In a study by Yu et al., hydrogen was
applied as a treatment to human skin fibroblast exposed
to oxidative stress induced by high levels of glucose and
mannose. The results showed that hydrogen was able to
improve viability of the cells by exhibiting its antioxidant
properties and reducing oxidative products exposed to
high glucose and mannose. A loss in membrane poten-
tial was exhibited by cells exposed to high glucose and
mannose, when compared to the hydrogen treatment
group it was observed that hydrogen was able to reduce
the loss of membrane potential. The study concluded
that overall, hydrogen might be able to play a role in
managing oxidative damage in skin lesions induced by
diabetes mellitus [29].
Another study involving hydrogen and diabetes mel-
litus investigated the effects of hydrogen rich water
in vitro and in vivo. In the in vitro study, hydrogen rich
water was given as a treatment for ROS induced by α,β-
dicarbonyl compounds and glucose, which is commonto patients with type-2 diabetes. In the in vivo study hy-
drogen rich water was a treatment for SHR. Cg-Leprcp/
NDmcr rats, an animal model for metabolic syndrome.
The results showed that hydrogen rich water was in both
in vitro and in vivo studies. When in vitro, hydrogen
was able to reduce ROS, when analyzed in vivo, hy-
drogen was also able to reduce renal ROS too. These
findings indicate that hydrogen rich water may be a pro-
spective treatment for renal dysfunction in type-2 dia-
betes mellitus patients [30].
One study using streptozotocin-induced diabetic rats,
analyzed the affects of hydrogen rich saline on erectile
dysfunction. Erectile dysfunction is more widespread in
men with diabetes mellitus than men without the di-
sease. The data shows that there was increased expres-
sion of endothelial nitric oxide synthase and increased
nitrite and nitrate levels in the corpus cavernosum for
the treatment group. Indicating that hydrogen might
have restored nitric oxide vasodilation and erectile func-
tion via endothelial nitric oxide synthase. Treatment
with hydrogen rich saline also revealed that hydrogen re-
stored expression of the anti-apoptotic factor, bcl-2, and
decreased protein expression of bax, a pro-apoptotic fac-
tor, in the corpus cavernosum, when compared to the
controls and diabetic groups. Altogether the results sug-
gest hydrogen rich saline may be an effective therapy to
erectile dysfunction in humans as well [18].
Another study involving hydrogen and diabetes mel-
litus observed the effects of hydrogen rich saline on a
diabetic rat model as well as an insulin resistant rat
model. The results of the study seem to suggest that hy-
drogen rich saline may have had an anti-lipidemic effect.
Hydrogen rich saline as a treatment for both the diabetic
rat model and the insulin resistant rat model may have
acted like an anti-lipidemic agent, since the levels of
total cholesterol, triglyceride, and low-density lipopro-
teins were all significantly lowered. These findings are
significant because it implies that hydrogen rich saline
may be able to play a therapeutic role in insulin resis-
tance and diabetes mellitus [31].
Based upon the knowledge that hydrogen has the ca-
pability to reduce oxidative stress, several clinical trials
have been performed. Since there are few clinical trials,
studies issue warnings about the interpretation of the
data found. In order for hydrogen to advance, more cli-
nical trials are needed to fully ascertain the effectiveness
of the therapy [32].
In a clinical trial performed by Kajiyama et al., the
effects of hydrogen rich water on patients with type 2
diabetes mellitus and impaired glucose tolerance were
examined. The study was a randomized, double-blind,
placebo-controlled, crossover study that involved 30 dia-
betes mellitus patients and 6 impaired glucose patients.
Each patient was subjected to 900 ml of hydrogen rich
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12-week wash out period. The results revealed that
hydrogen rich water increased extra cellular superoxide
dismutase and serum adiponectin levels, which is impli-
cated in improving insulin resistance. The results of the
study also revealed that hydrogen rich water was able to
reduce serum modified LDL levels as well as normalize
the glucose tolerance levels in 4 of the 6 total patients.
Indicating that hydrogen rich water aids lipid and glu-
cose metabolism. The conclusion made was that hydro-
gen rich water has benefits in preventing or impeding
type 2 diabetes mellitus and insulin resistance, because
of its ability to effectively reduce oxidative stress. In spite
of these exciting results and conclusions, Kajiyama et al.,
stated that a much larger clinical study is needed since
this study was relatively small and a warning that cau-
tion should be used when interpreting the data [32].
There have been quite a few studies involving molecu-
lar hydrogen directly as a treatment for the various con-
ditions and secondary complications that comprise or
are caused by diabetes mellitus. The studies indicate that
hydrogen maybe a novel therapy to diabetic complica-
tions and have a possible therapeutic role in diabetes
mellitus itself.
Alzheimer’s disease
Recently new connections concerning the pathogenesis
of Alzheimer’s disease and oxidative stress have been
made. However, there have only been a few studies di-
rectly involving hydrogen therapy in Alzheimer’s disease
[33].
A study performed by Li et al., wanted to know if
hydrogen rich saline had an effect on inflammation
caused by amyloid β and learning and memory. After in-
tracerebral ventricular injection of the amyloid peptide,
Aβ1-42, there was an increase in MDA, IL-6, and TNF-
α were all observed. After hydrogen rich saline was ad-
ministered as a treatment, reductions in these parame-
ters were also observed. It is also suggested that the
major findings of this study is that hydrogen rich saline
was able to improve long-term potentiation, learning,
and memory most likely by reducing inflammation and
oxidative stress. These assumptions were verified by re-
sults of improved response to inflammation and the
inhibition of accumulating lipid peroxidation products
[34,35].
Evidence that hydrogen rich saline is able to inhibit
the activation of c-Jun NH2-terminal kinase (JNK) and
nuclear factor-κB (NF-κB) has also been shown in the
Aβ1-42 Alzheimer’s diseases rat model. The attenu-
ation of JNK and NF-κB is a critical finding since it
has been previously shown that amyloid induces apop-
tosis through oxidative stress resulting from these path-
ways [35].Cerebrovascular diseases
The effects of hydrogen therapy in cebrovascular dis-
eases has shown a lot of promise since there are a
myriad of positive results showing molecular hydrogen
efficacy in this field of study. The effect of molecular
hydrogen therapy has been analyzed in various mediums
and in numerous animal models. Cai et al. found that
hydrogen gas was able to show anti-apoptotic proper-
ties by reducing cell death and limiting the activity of
caspase-3 and caspase-12, and thus increasing cell sur-
vivability in the neonatal hypoxia ischemia rat model.
Cai et al. proposed that hydrogen was able to hinder
apoptosis by quelling free radicals that trigger pathways
that lead to the activation of caspase-3. Cai et al. also an-
alyzed the short and long term effects of hydrogen rich
saline in a neonatal hypoxia ischemia model. The short-
term results suggested that hydrogen rich saline was able
to reduce the infarct ratio, cell death via apoptosis, oxi-
dative stress, as well as prevent caspase-3 and microglia
activity causing an overall long-term neurological im-
provement after the brain injury [19]. These findings
lead to the conclusion that hydrogen therapy may be a
possible agent in dealing with hypoxia ischemia and
other neonatal brain disorders [19,36].
In addition to antioxidant properties, hydrogen rich
saline has also been shown to have anti-inflammatory
properties and was able to reduce expression and activity
of TNF-α, NF-κB, and IL-6 after transient ischemia and
reperfusion in rats [37]. Similar results of a reduction in
oxidative stress and inflammation along with an up
regulation of Bcl-2 and down regulation of Bax and
caspase-3 were seen by Liu et al. in a focal ischemia and
reperfusion rat model [38].
Hydrogen rich water has also shown some effective-
ness in cerebrovascular injuries by preventing super-
oxide formation in brain slices of SMP30/SNL knockout
mice. Sato et al. speculates that molecular hydrogen may
be able to protect against ROS by translocating to the
nucleus and affecting gene transcription or by preven-
ting production by acting on the mitochondria itself
[39].
Fu et al. found that hydrogen rich water may also
be able to play a therapeutic role in impeding the ad-
vancement of Parkinson’s Disease. This conclusion was
reached after evaluating the results of behavior and
pathological examinations and discovering that the ap-
plication of the hydrogen rich water was able to protect
against 6-hydroxydopamine-induced nigrostriatal degen-
eration by reducing oxidative stress [40]. Related results
were also seen by Ito et al. who found that intermittent
hydrogen gas exposure seemed to be effective in pre-
venting 6-hydroxydopamine-induced Parkinson’s Disease
in rats, although not at the same efficacy as hydrogen
rich water [41]. Fujita et al. found similar results in
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veyed that hydrogen rich water was able to protect
against neuronal apoptosis induced by 1-methyl-4pheny-
l, 2, 3, 6-tetrahydropyridine by reducing ROS production
[42].
A randomized double-blind placebo-controlled trial
involving human patients conducted by Yoritaka et al.
demonstrated that hydrogen rich water was able to
reduce oxidative stress and improve Parkinson’s fea-
tures. This was indicated by improved Total Unified
Parkinson’s Disease Rating Scale scores in a majority of
the patients that consumed hydrogen rich water after
48 weeks. Although the results are promising, Yoritaka
et al. suggests that longer and larger trials should be
conducted in order to fully ascertain the effects of
hydrogen rich water in Parkinson’s Disease. To the
knowledge of Yoritaka et al. this is the first randomized
double-blind, placebo-controlled, parallel-grouptrial in-
volving hydrogen rich water and humans [43]. Domoki
et al. are among the first to ever demonstrate the effect-
iveness of hydrogen supplemented room air ventilation
as a therapeutic agent after perinatal asphyxia in a piglet
animal model. Treatment with hydrogen supplemented
room air ventilation was able to preserve cerbrovascular
reactivity and be instrumental in protecting neurons.
Which lead to the conclusion that hydrogen supple-
mented room air can provide early neuroprotection after
asphyxia, further studies are needed in order to identify
the full capabilities of neuroprotection [22]. Hugyecz
et al. also demonstrated how hydrogen supplemented
room air ventilation is able to reduce the activity of
cyclooxygenase-2 (COX-2) in the hippocampus after
transient global cerebral ischemia leading to reduced
neuronal damage due to truncated ROS production [20].
Experiments have also shown that hydrogen gas is ef-
fective in traumatic brain injuries and has neuropro-
tective properties as well. Ji et al. demonstrated that
hydrogen gas is able to hinder the permeability of the
blood brain barrier, reduce brain edema, and decrease
neurological dysfuntion by reducing ROS and oxidative
stress in rats after the traumatic brain injury [44].
Manaenko et al. also showed that hydrogen gas inhal-
ation is a beneficial agent in an intracerebral hemorrhage
mouse model. Hydrogen gas was able to improve neuro-
logical functions, decelerate blood brain barrier perme-
ability, as well as decrease the accretion of mast cells
causing a decrease in mast-cell specific proteins and pro-
duction of reactive oxygen and nitrogen species [45].
Although the efficacy results involving molecular hy-
drogen are positive there are some limitations. Matchett
et al. reported that hydrogen gas is ineffective when
moderate to severe damage occurred in a neonatal hy-
poxic rat model. The results indicate that it is possible
that severe ischemia damage may have overwhelmed theeffects of hydrogen treatment. This indicates that longer
exposure to hydrogen, or different concentrations may
have a more beneficial effect, or that hydrogen may only
be effective in mild cases of brain injury [46].
There are some limitations to hydrogen rich saline as
well. It has been shown that hydrogen rich saline may
only be able to reduce ROS and damage caused by ROS
directly after injury. This limits hydrogen rich saline
since clinically most of the damage is caused six to
twenty-four hours following injuries [37]. In addition,
evidence has shown that the neuroprotective effects of
molecular hydrogen may vary by animal model. Al-
though further studies are definitely necessary, based
upon the evidence it is reasonable to conclude that mo-
lecular hydrogen therapy may be safe and novel thera-
peutic treatment to various types of brain injuries and
cerebrovascular disease [44]. Safe and novel therapy so-
lutions are really needed in the United States, especially
since approximately 800,000 American people undergo
neurological procedures each year [47].
Chronic lower respiratory
Molecular hydrogen has been observed as a therapeutic
agent in acute and chronic respiratory diseases and in
many experiments has shown potential to be a potential
therapy. The application of hydrogen has shown diffe-
rent efficacies in relation to the various mediums.
One promising event was the effects of hydrogen rich
saline on lung injuries induced by intestinal ischemia
and reperfusion observed by Mao et al. In this experi-
ment it was observed that hydrogen rich saline was able
to reduce MDA levels after reperfusion when compared
to the control group. Also the effects of the hydrogen
rich saline treatment could be seen histologically, with
the observation of moderate edema inflammatory cell in-
filtration, and hemorrhage [48].
In addition, Fang et al., demonstrated the effects of
hydrogen rich saline by inducing lung injuries by means
of an extensive burn rat model. It was found that hy-
drogen treatment was able to improve the pulmonary
oxygenation function in severely burned rats due to its
ability to decrease inflammation cascades promoted by
TNF-α and IL-1, which resulted in a higher partial pres-
sure to oxygen when compared to the controls [49].
Sun et al., also found similar results and was able to
demonstrate that hydrogen rich saline had an effect on
hyperoxia lung injuries. The usage of hydrogen rich sa-
line, resulted in reduced levels of pro-inflammatory cyto-
kines and ROS. These reductions lead to reduced lung
injury and lung cell apoptosis [50].
Wang et al., who used hydrogen rich saline as treatment
for pulmonary hypertension, also reported the familiar
outcomes of decreased amounts of pro-inflammatory cy-
tokines. The results of this study also provided evidence of
Dixon et al. Medical Gas Research 2013, 3:10 Page 9 of 12
http://www.medicalgasresearch.com/content/3/1/10decreased ROS production and increased antioxidant ac-
tivity. This shows that hydrogen rich saline may in fact be
beneficial for pulmonary hypertension in rats [51].
Shi et al., has reported that treatment with hydrogen
rich saline may prevent lung cell apoptosis by directly or
indirectly affecting caspase-3 in cases of acute pulmo-
nary ischemia and reperfusion. Shi et al. saw decreased
amounts of caspase-3 activity when compared to the
control groups, indicating that hydrogen may be active
in the apoptotic pathway. Since the apoptotic pathway is
rather complex and contains a variety of variables fur-
ther studies should be conducted on the role of hydro-
gen in the activation of caspase-3 [52].
All these results seem to indicate that hydrogen rich
mediums; especially hydrogen rich saline may be an ef-
fective treatment for lower respiratory and lung asso-
ciated diseases by preventing the accumulation of ROS
and pro-inflammatory cytokines. Wang et al., concludes
that although the results are very promising, the time-
course analysis and a thorough mechanism of molecular
hydrogen affects on pulmonary hypertension and subse-
quently all pulmonary or pulmonary associated diseases
are necessary to determine whether or not hydrogen rich
saline has preventative or even therapeutic effects [51].
Malignant neoplasms
Malignant neoplasms or cancer is the second cause of
death in the United States. The effects of molecular hy-
drogen in cancerous disease states have been previously
documented and it is reported that hydrogen may have
therapeutic potential.
It has been shown that hydrogen rich water had an ef-
fect on inhibiting tumor growth as a result of its ability
to reduce oxidation products. The evidence for molecu-
lar hydrogen inhibition of tumor growth was shown by
Saitoh et al., Human tongue carcinoma cells HSC-4,
cultured with hydrogen showed a decrease in colony
numbers by 72% along with the number per colony de-
creasing by 66%. Human fibrosarcoma cells incubated
with the hydrogen rich water also showed similar re-
sponses, as a significant decrease in colonies was ob-
served as well [53].
Another observation in cancer research involves hy-
drogen rich saline. A study found that molecular hydro-
gen was instrumental in protecting mice from radiation
induced thymic lymphomas. The results also showed
that hydrogen treatment was able to slow the rate of ra-
diation induced thymic lymphomas as well as prolong
the latency period by reducing ROS, which has been
found to be a factor of inducing cancers [54].
Although there have been some positive results of hy-
drogen being a treatment for cancer by reducing ROS
more inquiries are needed and required to pass judgment.
Especially since ROS production is often employed as acommon therapeutic approach to help induce apoptosis in
cancer cells and combat cancer. On the other hand, ROS
has also been implicated in the induction and conserva-
tion of cancer. Thus it is important that more studies be
performed in order to fully assess all of the capabilities of
hydrogen therapy in cancer [55].
Cardiovascular
The effects of molecular hydrogen on the cardiovascular
system have been fairly well documented when com-
pared to other systems, diseases, and causes of death.
Since heart disease is the number one cause of death in
America it is imperative to have treatments against the
disease. Although the results involving hydrogen and the
heart have been positive in animal models, there still has
not been any clinical trials or hints of movement to-
ward clinical trials in the near future despite promi-
sing results.
Ionizing radiation-induced damage of the heart has
been shown to lead to chronic cardiac disease. Irrad-
iation of the heart has been shown to be caused by the
hydroxyl radical, intervention to protect the heart from
the damage of the hydroxyl radical has been proposed,
suggested, and performed by Qian et al., who have inves-
tigated the cardioprotective properties of hydrogen by
pre-treating mice with hydrogen rich water prior to ir-
radiation. The results were pleasing, 90% of the mice
without hydrogen rich water pretreatment died, while
80% of the mice with hydrogen treatment lived after 13
days post-radiation. When focusing on the myocardium,
hydrogen pre-treatment proved to have cardioprotective
properties by decreasing melanodialdehyde (MDA) and
eight-hydroxydeoxyguanosine (8-OHdG) levels as op-
posed to the non-treatment counterparts, which showed
increased levels of those oxidative stress markers [56].
Zhang et al. performed a study to analyze the anti-
inflammatory of hydrogen rich saline on rats that
received a left anterior descending coronary artery oc-
clusion. The results showed that hydrogen rich saline
has anti-inflammatory and cytoprotective properties by
decreasing pro-inflammatory cytokines and decreasing
myocardial cell damage caused by the adhesion molecule
ICAM-1 after ischemia and reperfusion injury [57]. A
study performed by Sun et al., demonstrated that hydro-
gen rich saline was able to be effective against myocar-
dial ischemia and reperfusion injury in rats. The findings
of this study were that there were significant decreases
in infarct sizes, MDA concentrations and 8-OHdG le-
vels in at risk areas, as well as evidence that hydrogen
was able to inhibit the affects of caspase-3, and inhibit
apoptosis in cardiomyocytes [13]. Hydrogen gas, at in-
combustible levels has also exhibited cardioprotective
properties. In a study by Hayashida et al., hydrogen
gas was shown to reduce myocardial infarct sizes that
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also suggests and concludes that the use of hydrogen gas
may have a clinical application now by using hydrogen
gas treatment in conjunction with routine percutaneous
coronary intervention procedures [58]. Overall, molecu-
lar hydrogen via gas, water or saline has proved to be ef-
fective at reducing various types of damage caused by
inflammation, radiation, and ischemia and reperfusion.
After the reporting the appealing results, Sun et al., con-
cluded in their study that molecular hydrogen speci-
fically “Hydrogen rich saline may, on the basis of our
observation, offer a simple, easy to use, safe, and economic
novel approach for future cardiac protection” [13].
The future
Currently there is only one active clinical trial concer-
ning molecular hydrogen as a therapy. The study in-
volves the evaluation of hydrogen administered orally
and topically as a therapy for sports-related soft tissue
injuries. This study aims to measure and observe chan-
ges in serum interleukin 6, plasma viscosity, passive joint
flexibility, joint swelling, pain intensity, and serum C-
reactive protein. This is currently a Phase 2 clinical trial
and hopefully the outcome of this clinical trial will be
promising and lead to more clinical trials involving
hydrogen rich formulations in the future [24].
It has been reported that many previous antioxidant
therapy treatments have had disappointing results in
clinical trials [59]. The disappointments and problems
that arose resulted in antioxidant therapy being per-
ceived as negative or tainted. This tainted image is
thought to be due to a lack of knowledge concerning an-
tioxidants. In order to achieve better results in clinical
trials it is proposed that knowledge involving the effects
of excess accumulation, the reducing potential, the do-
sage, the dose duration, and safety of the antioxidant
should all be determined [60].
Information about hydrogen as an antioxidant therapy
meets all of the proposed requirements to a certain
extent. Even though the exact mechanism is unknown,
it is also known that molecular hydrogen has the ability
to scavenge and reduce hydroxyl radicals, which can
lead to a decrease in oxidative stress because of fewer
amounts of free radicals and ROS. As for the dosage and
dosage duration, a universal standard concentration has
not been created, since the effectiveness of hydrogen
seems to vary by animal model [44]. However, numerous
experiments have been published with promising results
from various concentrations of hydrogen administered
either via gas, saline, or water. One example can be seen
in a recent experiment published by Itoh et al., which
made the conclusion that hydrogen is “likely to be instru-
mental in exerting a protective effect against Parkinson’s
disease” [41]. The pilot study that discovered that thescavenging ability of hydrogen significantly improved
symptoms of rheumatoid arthritis, also suggests that hy-
drogen can be used as a therapy in this capacity as well.
The safety of hydrogen has also been explored and
documented. The effects of excess accumulation has been
reported and speculated to be negligible. It has also been
discovered that hydrogen poses no risks for explosion or
flammability at concentrations less than 4.7 percent of air.
Hydrogen is often used in the field of diving and has
already been safely administered to prevent decompres-
sion sickness in divers [2]. Administration of hydrogen
rich saline has also been shown to significantly reduce
and protect against decompression sickness in rats [61].
This protection is most likely caused by anti-oxidation
properties of hydrogen. Which is compatible with the
notions that oxidative stress contributes to the develop-
ment of decompression sickness [62].
Conclusion
Studies on molecular hydrogen has come a long way
from its humble beginnings and has evolved tremen-
dously. There have been significant findings in the re-
search of molecular hydrogen, however progress needs
to continue. Molecular hydrogen has been involved in
very promising results thus far. In order for hydrogen
therapy to be effective in clinical trials and eventually
used in medicine, the exact mechanisms of how molecu-
lar hydrogen operates, needs to be fully discovered and
explored. The missing links of how hydrogen scavenges
the hydroxyl radical, and how hydrogen is involved in
cell signaling and activation, suppression of pathways,
how hydrogen interacts with other antioxidants to pro-
mote cytoprotection, and how hydrogen can reduce
inflammation are all important. Also the efficacy of spe-
cific concentrations in various disease models needs to
be determined as well as the optimal forms of adminis-
tration. The future looks very bright and promising;
hopefully hydrogen will be at the forefront of medicine
and will make surging strides as simple treatments to
the top ailments such as neurodegenerative diseases, car-
diovascular diseases, respiratory diseases, and a nume-
rous amount of other diseases.
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